Jarl Hellman

1.2k total citations · 1 hit paper
20 papers, 890 citations indexed

About

Jarl Hellman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Jarl Hellman has authored 20 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Genetics. Recurrent topics in Jarl Hellman's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (11 papers) and Pancreatic function and diabetes (6 papers). Jarl Hellman is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (11 papers) and Pancreatic function and diabetes (6 papers). Jarl Hellman collaborates with scholars based in Sweden, United States and Germany. Jarl Hellman's co-authors include Marcus Lind, Irl B. Hirsch, Arndís F. Ólafsdóttir, William H. Polonsky, Tim Heise, Sofia Dahlqvist, Jan Bolinder, Thomas Nyström, Hans Wedel and Anders Frid and has published in prestigious journals such as JAMA, Diabetes Care and Diabetes.

In The Last Decade

Jarl Hellman

19 papers receiving 849 citations

Hit Papers

Continuous Glucose Monitoring vs Conventional Therapy for... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jarl Hellman Sweden 9 766 470 434 66 62 20 890
Carlos Peñaherrera United States 10 60 0.1× 45 0.1× 295 0.7× 16 0.2× 2 0.0× 41 527
Roberta M. Hagaman United States 8 71 0.1× 31 0.1× 84 0.2× 3 0.0× 14 279
Jennifer Dow United States 11 12 0.0× 151 0.3× 26 0.1× 4 0.1× 6 0.1× 17 591
Nathan K. Itoga United States 14 45 0.1× 11 0.0× 356 0.8× 5 0.1× 3 0.0× 48 618
Audrey Béliveau Canada 6 17 0.0× 7 0.0× 61 0.1× 23 0.3× 11 0.2× 15 333
Shuichi Kitada Japan 13 34 0.0× 18 0.0× 259 0.6× 16 0.3× 39 466
Marion McDevitt United States 9 12 0.0× 132 0.3× 25 0.1× 4 0.1× 1 0.0× 16 540
Aiden O’Loughlin Australia 10 24 0.0× 14 0.0× 51 0.1× 19 0.3× 2 0.0× 32 363
Ghanshyam Shantha United States 11 66 0.1× 13 0.0× 73 0.2× 5 0.1× 33 427
Badr Ibrahim France 10 19 0.0× 28 0.1× 116 0.3× 9 0.1× 24 320

Countries citing papers authored by Jarl Hellman

Since Specialization
Citations

This map shows the geographic impact of Jarl Hellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarl Hellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarl Hellman more than expected).

Fields of papers citing papers by Jarl Hellman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarl Hellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarl Hellman. The network helps show where Jarl Hellman may publish in the future.

Co-authorship network of co-authors of Jarl Hellman

This figure shows the co-authorship network connecting the top 25 collaborators of Jarl Hellman. A scholar is included among the top collaborators of Jarl Hellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarl Hellman. Jarl Hellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Björkgren, Ida, Helena Backman, Jarl Hellman, et al.. (2025). Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements. British Journal of Clinical Pharmacology.
2.
Imberg, Henrik, Irl B. Hirsch, Erik Schwarcz, et al.. (2024). Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia. 67(8). 1517–1526. 8 indexed citations
3.
Gummesson, Christina, Mattias Ekstedt, Jarl Hellman, et al.. (2023). Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity. BMC Medical Education. 23(1). 635–635. 11 indexed citations
4.
Hellman, Jarl, Niels Væver Hartvig, Anne Kaas, et al.. (2023). Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes. Diabetes Obesity and Metabolism. 26(1). 301–310. 8 indexed citations
5.
Eklund, Gustav, José Caballero-Corbalán, Jarl Hellman, et al.. (2023). Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms. Diabetes Therapy. 14(6). 953–965. 6 indexed citations
6.
Lind, Marcus, Sergiu‐Bogdan Catrina, Neda Rajamand Ekberg, et al.. (2023). Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study. Diabetes Therapy. 14(9). 1563–1575. 2 indexed citations
7.
Polonsky, William H., Henrik Imberg, Jarl Hellman, et al.. (2023). Treatment Satisfaction and Well-Being With Continuous Glucose Monitoring in People With Type 1 Diabetes: An Analysis Based on the GOLD Randomized Trial. Journal of Diabetes Science and Technology. 19(1). 143–152. 2 indexed citations
9.
Adolfsson, Peter, Niels Væver Hartvig, Anne Kaas, Jonas Bech Møller, & Jarl Hellman. (2020). Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen. Diabetes Technology & Therapeutics. 22(10). 709–718. 76 indexed citations
11.
Ólafsdóttir, Arndís F., Jan Bolinder, Tim Heise, et al.. (2020). The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial ( GOLD‐5 ). Diabetes Obesity and Metabolism. 23(2). 619–630. 8 indexed citations
12.
Lind, Marcus, Arndís F. Ólafsdóttir, Irl B. Hirsch, et al.. (2020). Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes Care. 44(1). 141–149. 22 indexed citations
13.
Rosengren, Björn E., Riitta Möller, Jarl Hellman, et al.. (2019). EPA – en modell för att träna och bedöma dagligt läkarjobb. Lund University Publications (Lund University). 116. 1–4. 2 indexed citations
14.
Adolfsson, Peter, Niels Væver Hartvig, Anne Kaas, et al.. (2019). 126-LB: Improved Insulin Adherence after Introduction of a Smart Connected Insulin Pen. Diabetes. 68(Supplement_1). 5 indexed citations
15.
Rosengren, Björn E., Riitta Möller, Jarl Hellman, et al.. (2019). [EPA (Entrustable professional activities) - an international approach to define key tasks that a doctor should be able to perform].. PubMed. 116. 2 indexed citations
16.
Adolfsson, Peter, Niels Væver Hartvig, Anne Kaas, et al.. (2019). 1076-P: Increased Time-in-Range (TIR) Observed after Introduction of a Connected Insulin Pen. Diabetes. 68(Supplement_1). 3 indexed citations
18.
Lind, Marcus, William H. Polonsky, Irl B. Hirsch, et al.. (2017). Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. JAMA. 317(4). 379–379. 529 indexed citations breakdown →
19.
Hellman, Jarl, et al.. (1970). Firebrand trajectory study using an empirical velocity-dependent burning law. Combustion and Flame. 15(3). 265–274. 39 indexed citations
20.
Hellman, Jarl, et al.. (1969). Study of firebrand trajectories in a turbulent swirling natural convection plume. Combustion and Flame. 13(6). 645–655. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026